We additionally noted if any of those phenotypes were in one of four AD relevant categories: I) dementia; II) AD biomarkers such as TREM2 or Tau; III) other neurological or psychiatric traits such as depression, stroke, or schizophrenia; and IV) AD risk factors such as, cancer, heart disease, or diet. The gene discussed is MAPT; the disease is schizophrenia.